Namib Minerals to restart mothballed Zimbabwe gold mine in February
Redwing currently has an estimated 2.5 million ounces of gold and is the largest resource base in the group's Zimbabwean portfolio.
Amplia Therapeutics CEO outlines 2023 milestones
(via NewsDirect)
Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns speaks with Proactive following his move into the leadership role late last year. Amplia is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in cancer and Amplia has a particular development focus in fibrotic tumours such as pancreatic and ovarian cancers.
Contact Details
Proactive Investors
Jonathan Jackson
+61 413 713 744
Copyright (c) 2023 TheNewswire - All rights reserved.
